| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Carole Nuechterlein | Director | $8.34M | Jun 27, 2024 | ||
| Lawrence Blatt | Chief Executive Officer, Director | $1.41M | Sep 4, 2024 | ||
| James Scopa | Director | $139K | Jun 27, 2024 | ||
| Roche Holding Ltd | 10%+ Owner | Oct 25, 2023 | |||
| Jack Nielsen | Director | Feb 27, 2024 | |||
| Thomas Woiwode | Director | Jun 23, 2022 | |||
| Bridget Martell | Director | Jun 27, 2024 | |||
| Heather Preston | Director | Aug 7, 2024 | |||
| Leonid Beigelman | President, Director | Mar 15, 2023 | |||
| Lucinda Y. Quan | Executive Vice President, Chief Business Officer and General Counsel | Sep 8, 2023 | |||
| Julian A. Symons | Executive Vice President, Chief Scientific Officer | Sep 4, 2024 | |||
| Matthew W. McClure | Chief Medical Officer | Mar 1, 2024 | |||
| Peter Hirth | Director | Jun 27, 2024 | |||
| Lesley Ann Calhoun | Chief Financial Officer | Sep 4, 2024 | |||
| Margarita Chavez | Director | Aug 7, 2024 | |||
| Hardean Achneck | Chief Medical Officer | Oct 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|